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Brain-intrinsic degenerative cascades have beenproposed tobe an initial factor driving lesion formation inmultiple sclerosis (MS).Here,
we identifyneurodegenerationas apotent trigger forperipheral immunecell recruitment into themouse forebrain. FemaleC57BL/6mice
were fed cuprizone for 3 weeks, followed by a period of 2 weeks on normal chow to induce the formation of lesion foci in the forebrain.
Subsequent immunization with myelin oligodendrocyte glycoprotein 35–55 peptide, which induces myelin autoreactive T cells in the
periphery, resulted in massive immune cell recruitment into the affected forebrain. Additional adoptive transfer experiments together
with flowcytometry analysis underline the importanceof brain-derived signals for immune cell recruitment. This study clearly illustrates
the significance of brain-intrinsic degenerative cascades for immune cell recruitment andMS lesion formation. Additional studies have
to address the signaling cascades and mechanistic processes that form the top-down communication between the affected brain area,
neurovascular unit, and peripheral immune cells.
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Introduction
Histopathological characteristics of multiple sclerosis (MS) le-
sions include oligodendrocyte death, demyelination, gliosis, ax-
onal damage, and peripheral immune cell invasion.However, it is
not entirely clear whichmechanisms regulate the development of
new inflammatory brain lesions. Although some reports suggest a
key role for adaptive immunity during the earliest stages of lesion
genesis (Lucchinetti et al., 2000; Maggi et al., 2014), others have
proposed that neurodegenerative events are the initial factors
driving MS lesion formation, including oligodendrocyte death,
focal microglia activation, and axonal damage (Barnett and Pri-
neas, 2004). This series of events was recently termed “inside-
outside model” (Stys et al., 2012). Locatelli et al. (2012)
investigated the initiation ofMS-like pathology in amousemodel
in which the diphtheria toxin receptor is specifically expressed in
oligodendrocytes. Despite diphtheria toxin-induced neurode-
generation, even conditions favoring autoimmunity—bystander
activation, removal of regulatory T (Treg) cells, and application of
demyelinating antibodies—did not result in peripheral immune
cell formation. The authors concluded that oligodendrocyte
death with concomitant reactive gliosis is not sufficient to trigger
CNS inflammation. However, it is not clear whether a neurode-
generative process represents an important catalyst for immune
cell recruitment from the “outside” compartment if encephalito-
genic T cells are present there in a relevant number. Several stud-
ies have reported the dissociation between inflammation-driven
relapses and clinical progression in MS (Kremenchutzky et al.,
2006; Scalfari et al., 2010). Furthermore, dissociation between
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Significance Statement
We identify neurodegeneration as a potent trigger for peripheral immune cell recruitment into the forebrain. Thus, immune cell
recruitmentmight be a second step during the formation of new inflammatory lesions inmultiple sclerosis. A better understand-
ing of factors regulating neurodegeneration-induced immune cell recruitment will pave the way for the development of novel
therapeutic treatment strategies.
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therapeutic effects on relapse frequency versus effects on progres-
sion of disability became clear in clinical trials (Coles et al., 1999;
Rice et al., 2000). Therefore, a better understanding of the inter-
play of both variables is needed. Recently published data suggest
that neurodegeneration indeed can trigger immune cell recruit-
ment into the brain parenchyma (Baxi et al., 2015).
To further test this hypothesis, we combined a classical “neu-
rodegenerative” and a classical autoimmune MS animal model.
In the cuprizone (Cup) model, rodents are fed the copper chela-
tor Cup, which results in varying degrees of oligodendroglial
damage, demyelination gliosis, and axonal destruction (i.e., neu-
rodegeneration) in the CNS with little, if any, autoimmune reac-
tion (Kipp et al., 2009). Neurodegenerative foci are found
widespread within the brain, including distinct forebrain areas
such as the hippocampus, corpus callosum, and cortex. In active
experimental autoimmune encephalomyelitis (EAE), sensitiza-
tion to distinct myelin antigens, such as myelin oligodendrocyte
glycoprotein 35–55 (MOG) peptide, results in immune cell re-
cruitment into the CNS with subsequent autoimmune-driven
inflammation and demyelination. Remarkably, lesions in MOG-
immunized animals predominantly arise in the spinal cord and
cerebellum.
Here, we demonstrate that peripheral immune cells do not
invade the forebrain in MOG-induced EAE under standard con-
ditions. However, severe forebrain inflammation is evident if an-
imals are pre-intoxicated with Cup. Adoptive transfer (AT)
experiments together with flow cytometry analysis underline the
importance of brain-derived signals for the observed immune cell
recruitment. Together, we provide clear evidence that the degen-
eration caused byCup treatment acts as a trigger for immune cells
to enter the forebrain.
Materials andMethods
Animals.C57BL/6 femalemice (Janvier) were used. Food andwater were
available ad libitum. All experimental procedures were approved by the
Review Board for the Care of Animal Subjects of the district government.
Experimental induction of neurodegeneration and autoreactive T-cell
formation. In general, to induce neurodegeneration of the forebrain,
mice received a diet containing 0.25% Cup (Sigma-Aldrich) for 3 weeks
mixed into a ground standard rodent chow, followed by a period of 2
weeks on normal chow to allow autonomous lesion progression (Doan et
al., 2013). Animals were then assigned randomly to experimental groups.
Histopathological stainings of such lesions were already published pre-
viously (Grosse-Veldmann et al., 2015). The formation of myelin auto-
reactive T cells was achieved by immunizationwith an emulsion ofMOG
dissolved in complete Freund’s adjuvant (CFA), followed by administra-
tion of pertussis toxin (PTX) in PBS, first on the day of immunization
and then again the following day (i.e., active EAE). A ready-to-use kit
provided byHooke Laboratories was used. Scoring of disease severitywas
performed as published previously (Kipp et al., 2011). Mice that did not
present with clinical scores were not included in subsequent analyses
(n 4).
AT experiments. For classical AT experiments, female C57BL/6 donor
micewere immunized as described above and used as a source of enceph-
alitogenic T cells. Once donor mice developed a clinical response to
MOG (11 d after active immunization), they were killed, and their
spleens harvested. To induce in vitro clonal expansion of MOG-reactive
lymphocytes, cells were cultured in the presence ofMOG (20g peptide/
ml; Hooke Laboratories), IL12 peptide (20 ng/ml; Peprotech), and anti-
mouse IFN antibodies (10 g/ml; Peprotech) for 72 h. Subsequently,
20–30 million cells were injected via the tail vein into mice with or
without previous Cup-induced neurodegeneration (see above). In addi-
tional experiments, spleens were harvested from Cup-treated animals,
processed and cultured as described above, and injected via the tail vein
intomicewith orwithout previousCup-inducedneurodegeneration (see
Fig. 2C; Cup-AT in co and Cup-AT in cup). This part of the experiment
was designed to investigate whether autoreactive T cells are generated in
Cup-exposed animals.
Histological, immunohistological, and mRNA-level evaluation. Tissue
sampling and processingwere performed following established protocols
(Clarner et al., 2015). Before paraffin embedding, spinal cord tissueswere
incubated in EDTA solution for 48 h at 37°C. For the quantification of
perivascular infiltrates within the forebrain, three H&E-stained brain
sections at the levels 215, 245, and 265 according to themouse brain atlas
by Sidman et al. (http://www.hms.harvard.edu/research/brain/atlas.
html) were evaluated by two blinded observers, and the results were
averaged. Subsequent slides were evaluated for the quantity of parenchy-
mal cluster of differentiation 3-positive (CD3) cells in the white matter
tract corpus callosum if appropriate. Cell quantification approaches have
been performed as published recently (Slowik et al., 2015). Gene expres-
sion analyses were performed as published previously (Clarner et al.,
2015). To analyze the presence of lipids in cervical lymph nodes of Cup-
treated animals, OilRedO (ORO) stains of cryosections were performed
using a ready-to-use kit (Abcam) following the instructions of the
manufacturer.
Flow cytometry analysis. For cell surface staining, single-cell suspen-
sions were prepared from spleens or cervical lymph nodes and stained
with the following antibodies: anti-CD3–Allophycocyanin (APC) (eBio-
science), anti-CD4–Pacific Blue (PB; eBioscience), anti-CD25–Phyco-
erythrin (PE) (eBioscience), anti-Gr-1–PE (eBioscience), and anti-
CD11b–PB (eBioscience). Intracellular staining of FoxP–FITC
(eBioscience)was performedusing eBioscience FoxP3 staining buffer kit,
according to the instructions of the manufacturer. For measurement of
intracellular IL17 production, cells were treatedwith PMA(20nM), iono-
mycin (2 M) (both from Sigma-Aldrich), and GolgiPlug (BD Biosci-
ence) for 5 h, and intracellular staining was performed with anti-IL17–
Alexa Fluor 488 (eBioscience) using eBioscience FoxP3 staining buffer
kit. Samples were analyzed using a FACS Canto II (BD Biosciences), and
data were analyzed using FCS Express (De Novo Software) software.
Statistical analysis. For comparative clinical scoring, 39 animals were
assigned to theMOGEAE group and 31 to the Cup/MOG group. In each
group, two animals did not show clinical signs and were therefore ex-
cluded. If not stated otherwise, at least two independent experiments
were performed for each experimental group. All data are given as arith-
metic means  SEMs. Differences between groups were statistically
tested by Student’s t test using GraphPad Prism 5 (GraphPad Software).
p values 0.05 were considered to be statistically significant. The follow-
ing symbols were used to indicate the level of significance: *p  0.05,
***p 0.001. ns indicates not significant.
Results
First, animals were fed Cup to induce forebrain neurodegenera-
tion and were then immunized with MOG peptide (we refer to
this experimental group as Cup–MOG). In contrast to a previous
report (Man˜a et al., 2009), the severity of clinical symptoms in
classical MOG-immunized EAEmice was comparable in animals
with or without previous Cup intoxication. In particular, no sig-
nificant difference was observed for the parameters disease onset
(EAE, 11.24 0.47 vs Cup–MOG, 10.56 0.33 d after immuni-
zation; p 0.23) and maximum disease score (EAE, 2.31 0.19
vsCup–MOG, 2.3 0.18; p 0.94). In linewith this observation,
inflammatory infiltrates were found in the spinal cord of both
groups to a comparable extent (Fig. 1A). Such infiltrates were not
present in the spinal cord of control (co) andCup-fed animals. In
a next step, we analyzed the forebrain at distinct rostral-to-caudal
levels for the presence of perivascular infiltrates, a hallmark of
activeMS lesions (Maggi et al., 2014). Although such perivascular
infiltrates were virtually absent in the forebrain of co animals and
Cup and MOG-immunized animals, the forebrains of Cup–
MOG animals contained a significant number of perivascular
infiltrates (Fig. 1B). Such infiltrates were found widespread
within the forebrain, including the cortex, corpus callosum, and
subcortical regions (Fig. 1C). Remarkably, the number of
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perivascular infiltrates was largest at topographical sites par-
ticularly vulnerable in the Cup model (e.g., corpus callosum,
caudate-putamen, or deep cortical layers; Clarner et al., 2012).
The formation of endogenousmyelin-specific T cells appeared to
be essential for this process, because animals solely “immunized”
with CFA and PTX (lacking the MOG peptide) did not show
significant peripheral cell recruitment. Subsequent immunohis-
tochemical studies using anti-ionized calcium-binding adapter
molecule 1 (Iba1) and anti-CD3 displayed the recruitment of
monocytes and lymphocytes (Fig. 1D).
Peripheral leukocyte infiltration into the brain is tightly regu-
lated at the level of the postcapillary venules and involves two
distinct steps: (1) transmigration across the vascular wall into the
perivascular space (i.e., Virchow–Robin space); and (2) progres-
sion through the glia limitans perivascularis (Rezai-Zadeh et al.,
2009). A more detailed characterization of infiltrates revealed
that, based on the distribution of inflammatory cells, two distinct
lesion types could be discriminated: (1) lesions with inflamma-
tory cells residing within the perivascular spaces (Fig. 1E1); and
(2) lesions with inflammatory cells penetrating into the sur-
rounding brain parenchyma (Fig. 1E2). As shown in Figure 1, F1
and F2, parenchymal immune cell invasion was paralleled
by significant demyelination. Beyond, anti-Glial fibrillary acidic
protein (GFAP) and anti-aquaporin-4 (AQP4) stains revealed a
morphologically and functionally disrupted glia limitans perivas-
cularis in those lesions with immune cell invasion into the brain
parenchyma (Fig. 1G,H). The barrier of GFAP astrocyte foot
processes was discontinuous (Fig. 1G2), and AQP4 was found to
be focally absent (Fig. 1H2). Furthermore, we quantified the
number of parenchymal CD3 lymphocytes and found higher
numbers in Cup–MOG animals (Fig. 1I). In support of this no-
tion, gene expression analysis of a separate cohort of animals
displayed high forebrain expression of the T-cell receptors T3
delta (CD3d) and  (CD3e) chain inCup–MOGanimals. Expres-
sion of T-cell receptor–CD3 complex components were only de-
tected inminute amounts in all other groups (data not shown). A
consistent MS feature is the transient loss of vascular imperme-
ability (Cotton et al., 2003). Therefore, we tested whether ob-
served histopathological alterations are transient or permanent.
To this end, telencephalic lesions were induced as described
above. However, brains were analyzed 6 weeks after immuniza-
tion instead at the peak of disease. As shown in Figure 1J, anti-
GFAP stains showed a continuous layer of astrocyte end feet
around vessels at this later time point. Furthermore, anti-AQP4
stains did not show any signs of focal loss of immunoreactivity.
We next were interested whether a temporal correlation exists
between Cup-induced neurodegeneration and the phenomenon
of peripheral immune cell recruitment. To this end, animals were
fed Cup for 3 weeks. However, in contrast to the already de-
scribed experiments, MOG immunization was performed 4 in-
stead of 2 weeks after cessation of the Cup intoxication. As shown
in Figure 1K, immune cell recruitment was significantly lower
under this experimental setting.
So far, we were able to demonstrate that peripheral encepha-
litogenic immune cells invade the forebrain parenchyma in case a
neurodegenerative trigger is present before MOG immunization
is performed. As shown in Figure 2A, ORO-stained sections
showed a significant lipid increase in cervical lymph nodes of
Figure 1. A, Shows representative H&E-stained sections of the spinal cord (at the peak of the disease,2weeks after immunization). Arrowheads highlight inflammatory foci.B and C show the
number and spatial distributionof perivascular infiltrates in thedifferent treatment groups (H&E staining).D, Composition of perivascular infiltrates. Both CD3 lymphocytes and Iba1monocytes
can be found. E shows twodistinct lesion types: E1, perivascular lesions inwhich immune cells are trapped in the enlarged perivascular space; E2, where immune cells invaded the neuropil. Immune
cell neuropil invasion induces demyelination [Luxol fast blue (LFB)/periodic acid Schiff; F1, F2], the breakdown of the glia limitans perivascularis (anti-Glial fibrillary acidic protein; G1, G2, see
arrows), and astrocyte polarity loss (anti-AQP4;H1,H2). I, Quantification of CD3 cells into the neuropil. Arrow points at a CD3 lymphocyte within the neuropil. J shows the integrity of the glia
limitans perivascularis 6 weeks after immunization. Anti-Glial fibrillary acidic protein presents as a continuous layer of astrocyte end feet around vessels; focal loss of anti AQP-4 stain is not evident
anymore. K shows the cumulative number and spatial distribution of perivascular infiltrates after delayed MOG immunization (i.e., 4 instead of 2 weeks after Cup-induced neurodegeneration).
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Cup-treated animals, indicating transfer of myelin material after
Cup-induced neurodegeneration. Although we did not find an
altered T-cell phenotype in these lymph nodes (Fig. 2B), periph-
eral immune cell recruitment in our novel combinatory model
might occur as a consequence of released myelin debris during
the Cup intoxication period that is transported to cervical lymph
nodes. If present there in relevant amounts, local myelin antigens
might influence the immune cell repertoire during MOG immu-
nization. To check for this possibility, we first performedAT of in
vitro MOG-reactivated lymphocytes. To this end, donor mice
were immunized with MOG, killed at the first day of clinical
signs, and their spleens harvested. Clonal expansion of MOG-
reactive lymphocytes was accomplished in vitro, and 20–30
million cells were injected into mice with or without previous
Cup-induced neurodegeneration (for experimental setup, see
Fig. 2C). Cup-pretreated animals displayed the tendency of a
more delayed disease onset (AT, 9.2  0.73 vs Cup–AT, 10.8 
0.49 d after adoptive cell transfer; p 0.11), although this differ-
ence was not significant. Notably, mice fed Cup before adoptive
T-cell transfer (MOG-AT in cup) showed a higher number of
perivascular infiltrates compared with animals without previous
Cup feeding (MOG-AT in co; Fig. 2C). It should also be stipu-
lated that, if the same procedure was performed with splenocytes
isolated from Cup-treated animals, recipient mice, regardless of
being pre-intoxicated with Cup (Cup-AT in cup) or not
(Cup-AT in co), did not develop any clinical signs of EAE. This
indicates that no relevant numbers of autoreactive T cells are
generated in the Cup model. Furthermore, we analyzed the im-
mune cell signature in the spleen by means of flow cytometry.
As demonstrated in Figure 2D, numbers of T-helper 17 (Th17)
cells (IL17/CD3/CD4), Treg cells (CD25
/FoxP3/CD4),
memory T cells (CD62Llow/CD44high/CD4), and myeloid-
derived suppressor cells (CD11b/Gr1) were induced compa-
rably. Mean percentage of Th17 cells in CD3
/CD4
lymphocytes were 12.4  2.7% in EAE versus 8.4  1.2% in
Cup–MOG animals (p 0.24), andmean percentage of Treg cells
in CD4 lymphocytes were 8.1 0.4% in EAE versus 8.4 0.5%
in Cup–MOG animals (p 0.69). Comparable results were ob-
tained in isolated cervical lymph node cells (data not shown).
Furthermore, absolute cell numbers, total monocytes (F4–80
cells), and neutrophils were induced to a comparable extent in
the blood of either treatment group (data not shown).
Discussion
We investigated possible interactions between the injured
forebrain parenchyma and leukocytes after Cup-induced neu-
rodegeneration. Here, we demonstrate that neurodegenera-
tive processes within the forebrain are at the beginning of a
signaling cascade, which finally results in the recruitment of
peripheral leukocytes and in consequence in the formation of
a new, inflammatory, demyelinating lesion. The neurodegen-
Figure2. A, RepresentativeORO-stained cervical lymphnodes.White arrowheadshighlight lipid-ladenmacrophages.B shows relativenumbers of Th1, Th17, andTreg cells in cervical lymphnodes
before MOG immunization. Note that the immune cell repertoire is not altered as a result of the Cup intoxication. C shows the number of forebrain perivascular infiltrates in different treatment
groups. Note that perivascular infiltrates were virtually absent in co animals (i) and in animals in which cultured and stimulated splenocytes, isolated from Cup-exposed animals, were transferred
into either co animals (Cup-AT in co) or Cup-intoxicated animals (Cup-AT in cup; ii). In contrast, numerous perivascular infiltrates were present in classical AT experiments. Most importantly, the
number of forebrain perivascular infiltrates is greater in animalswith Cup-inducedneurodegeneration before T-cell transfer (MOG-AT in co vsMOG-AT in cup). PVC, Perivascular cuffs.D, Immune cell
repertoire in the spleen, determined by FACS analysis. The followingmarker setswere used: Th17 cells (IL17
/CD3/CD4), Treg cells (CD25
/FoxP3/CD4), memory T cells (Tmem; CD62L
low/
CD44 high/CD4), and myeloid-derived suppressor cells (CD11b/Gr1).
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erative process was induced by Cup feeding of adult mice for 3
weeks.
Two important aspects need to be discussedwith regard to the
relevance of our findings for MS pathogenesis. First, can neuro-
degeneration trigger a subsequent peripheral autoreactive im-
mune response that finally leads to lesion formation as seen in
MS? Second, is MS a disease where primary neurodegeneration
triggers immune cell recruitment to the sites of pathology? With
respect to the first question, we found no clear-cut evidence that
autoreactive T cells are generated in the Cup model (Fig. 2). The
numbers of Th1 and Th17 cells in peripheral lymphoid organs are
unaltered, and the transfer of isolated splenocytes from Cup-
exposed animals to recipient mice does not result in immune-
mediated CNS inflammation. These results are in line with
previous data presented by Locatelli et al. (2012). They showed
that, even in a strong proinflammatory experimental setting,my-
elin antigens in CNS-draining lymph nodes failed to initiate anti-
CNS immunity. Thus, our study does not support the concept
that anti-CNS immunity is attributable to a primary neurodegen-
erative event. Concerning the second question, our data suggest
that encephalitogenic T cells together with monocytes are re-
cruited to neurodegenerative lesion sites. The fact that neurode-
generative events can trigger the recruitment of peripheral
immune cells into the CNS has been shown in experimental par-
adigms of peripheral facial nerve injury (Raivich et al., 1998),
cortical cryoinjury, or eyeball enucleation (Konno et al., 1990).
We are the first to describe such a mechanism in an MS-relevant
context. It was our aim to model early MS-related degenerative
processes as closely as possible and therefore used the Cupmodel
that harbors several characteristics of earlyMS lesions. For exam-
ple, careful pathological examinations have revealed that the ear-
liest myelin abnormalities begin at the inner myelin sheath that
surrounds still-myelinated axons (Rodriguez and Scheithauer,
1994; Aboul-Enein et al., 2003). Such alterations can also be
found in the Cup model (Ludwin and Johnson, 1981). Further-
more, early MS lesions are characterized by selective oligoden-
drocyte degenerationwith focalmicroglia activation (DeGroot et
al., 2001; Barnett and Prineas, 2004). Both aspects are character-
istic for early Cup-induced lesions (Clarner et al., 2015).
Although the influx of peripheral immune cells into the CNS
is a well known phenomenon in MS, the initial stages of this
process are not well understood. To initiate CNS inflammation,
encephalitogenic T cells must be activated in the periphery, gain
access to the CNS, and then be reactivated by local antigen pre-
senting cells, which present CNS antigen. The anatomy of the
CNS poses unique challenges to this process because it is pro-
tected from cellular infiltration by specific borders, such as the
blood–brain barrier. Although this study, for obvious reasons,
does not answer the question of which factors contribute to en-
cephalitogenic T-cell activation in the periphery, we clearly show
that neurodegeneration orchestrates the important second step
of MS lesion development, i.e., immune cell recruitment. In the
absence of brain pathology, endothelial cells of the brain do not
express the adhesion molecules that are necessary for activated T
cells to adhere to the vessel wall. It is well known that astrocytes
are activated in theCupmodel (Kipp et al., 2011), and astrogliosis
has often been thought to contribute to lesion formation, for
example, by the secretion of chemokines. Because chemokine
expression is induced in the Cup model (Clarner et al., 2015),
we consider it likely that the Cup-induced brain pathology acti-
vates endothelial cells and subsequently facilitates the transmi-
gration of T cells across the blood–brain barrier. An important
question is howmany of the recruited T cells to the Cup-induced
lesion sites are autoreactive in this model and whether these are
reactivated once they have entered the brain. The precise identity
of the antigen-presenting cells responsible for reactivating CD4
T cells within the CNS is not known, but microglia are potential
candidates, especially at the onset of an inflammatory attack (Al-
molda et al., 2010). Because microglia activation is another car-
dinal feature of Cup-induced pathology, these cells might
reactivate T cells at lesion sites in the presented model.
Our findings clearly have direct clinical relevance. Most
approved MS drugs mainly harbor a peripheral mode of ac-
tion. If lesion development starts with an initial neurodegen-
erative process, neuroprotective therapies might not just
ameliorate the neurodegenerative but also the inflammatory
aspect of the disease. A better understanding of factors regu-
lating neurodegeneration-induced immune cell recruitment
will pave the way for the development of novel therapeutic
treatment strategies.
References
Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bru¨ck W,
Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H (2003) Prefer-
ential loss of myelin-associated glycoprotein reflects hypoxia-like white
matter damage in stroke and inflammatory brain diseases. J Neuropathol
Exp Neurol 62:25–33. Medline
Almolda B, Gonza´lez B, Castellano B (2010) Activated microglial cells ac-
quire an immature dendritic cell phenotype and may terminate the im-
mune response in an acute model of EAE. J Neuroimmunol 223:39–54.
CrossRef Medline
Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis:
pathology of the newly forming lesion. AnnNeurol 55:458–468. CrossRef
Medline
Baxi EG,DeBruin J, Tosi DM,Grishkan IV, SmithMD,Kirby LA, Strasburger
HJ, Fairchild AN, Calabresi PA, Gocke AR (2015) Transfer of myelin-
reactive th17 cells impairs endogenous remyelination in the central ner-
vous system of cuprizone-fed mice. J Neurosci 35:8626–8639. CrossRef
Medline
Clarner T, Diederichs F, Berger K, Denecke B, Gan L, van der Valk P, Beyer C,
Amor S, KippM (2012) Myelin debris regulates inflammatory responses
in an experimental demyelination animal model and multiple sclerosis
lesions. Glia 60:1468–1480. CrossRef Medline
Clarner T, Janssen K, Nellessen L, Stangel M, Skripuletz T, Krauspe B, Hess
FM, Denecke B, Beutner C, Linnartz-Gerlach B, NeumannH, Vallie`res L,
Amor S, Ohl K, Tenbrock K, Beyer C, Kipp M (2015) CXCL10 triggers
early microglial activation in the cuprizone model. J Immunol 194:
3400–3413. CrossRef Medline
Coles AJ, Wing MG, Molyneux P, Paolillo A, Davie CM, Hale G, Miller D,
WaldmannH, Compston A (1999) Monoclonal antibody treatment ex-
poses three mechanisms underlying the clinical course of multiple sclero-
sis. Ann Neurol 46:296–304. CrossRef Medline
Cotton F,Weiner HL, Jolesz FA, GuttmannCR (2003) MRI contrast uptake
in new lesions in relapsing-remitting MS followed at weekly intervals.
Neurology 60:640–646. CrossRef Medline
De Groot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F, van
der Valk P (2001) Post-mortemMRI-guided sampling of multiple scle-
rosis brain lesions: increased yield of active demyelinating and (p)reactive
lesions. Brain 124:1635–1645. CrossRef Medline
DoanV,Kleindienst AM,McMahonEJ, LongBR,MatsushimaGK,Taylor LC
(2013) Abbreviated exposure to cuprizone is sufficient to induce demy-
elination and oligodendrocyte loss. J Neurosci Res 91:363–373. CrossRef
Medline
Grosse-Veldmann R, Becker B, Amor S, van der Valk P, Beyer C, Kipp M
(2015) Lesion expansion in experimental demyelination animal models
and multiple sclerosis lesions. Mol Neurobiol. Advance online publica-
tion. Retrieved December 26, 2016. doi:10.1007/s12035-015-9420-y.
CrossRef Medline
KippM, Clarner T, Dang J, Copray S, Beyer C (2009) The cuprizone animal
model: new insights into an old story. Acta Neuropathol 118:723–736.
CrossRef Medline
KippM,Gingele S, Pott F, Clarner T, van derValk P,Denecke B,Gan L, Siffrin
V, Zipp F, Dreher W, Baumgartner W, Pfeifenbring S, Godbout R, Amor
1414 • J. Neurosci., January 27, 2016 • 36(4):1410–1415 Scheld, Ru¨ther et al. • Neurodegeneration Triggers Immune Cell Recruitment
S, Beyer C (2011) BLBP-expression in astrocytes during experimental
demyelination and in human multiple sclerosis lesions. Brain Behav Im-
mun 25:1554–1568. CrossRef Medline
Konno H, Yamamoto T, Suzuki H, Yamamoto H, Iwasaki Y, Ohara Y, Ter-
unuma H, Harata N (1990) Targeting of adoptively transferred experi-
mental allergic encephalitis lesion at the sites of wallerian degeneration.
Acta Neuropathol 80:521–526. CrossRef Medline
Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC
(2006) The natural history of multiple sclerosis: a geographically based
study 9: observations on the progressive phase of the disease. Brain 129:
584–594. CrossRef Medline
Locatelli G, Wo¨rtge S, Buch T, Ingold B, Frommer F, Sobottka B, Kru¨ger M,
KarramK, Bu¨hlmannC, Bechmann I, Heppner FL,Waisman A, Becher B
(2012) Primary oligodendrocyte death does not elicit anti-CNS immu-
nity. Nat Neurosci 15:543–550. CrossRef Medline
Lucchinetti C, Bru¨ck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H
(2000) Heterogeneity of multiple sclerosis lesions: implications for the
pathogenesis of demyelination. Ann Neurol 47:707–717. CrossRef
Medline
Ludwin SK, Johnson ES (1981) Evidence for a “dying-back” gliopathy in
demyelinating disease. Ann Neurol 9:301–305. CrossRef Medline
Maggi P, Macri SM, Gaita´n MI, Leibovitch E, Wholer JE, Knight HL, Ellis M,
Wu T, Silva AC, Massacesi L, Jacobson S, Westmoreland S, Reich DS
(2014) The formation of inflammatory demyelinated lesions in cerebral
white matter. Ann Neurol 76:594–608. CrossRef Medline
Man˜a P, Fordham SA, Staykova MA, Correcha M, Silva D, Willenborg DO,
Lin˜ares D (2009) Demyelination caused by the copper chelator cupri-
zone halts T cell mediated autoimmune neuroinflammation. J Neuroim-
munol 210:13–21. CrossRef Medline
RaivichG, Jones LL, Kloss CU,Werner A, NeumannH, Kreutzberg GW (1998)
Immune surveillance in the injured nervous system: T-lymphocytes invade
the axotomized mouse facial motor nucleus and aggregate around sites of
neuronal degeneration. J Neurosci 18:5804–5816. Medline
Rezai-Zadeh K, Gate D, Town T (2009) CNS infiltration of peripheral im-
mune cells: D-Day for neurodegenerative disease? J Neuroimmune Phar-
macol 4:462–475. CrossRef Medline
Rice GP, Filippi M, Comi G (2000) Cladribine and progressive MS: clinical
and MRI outcomes of a multicenter controlled trial. Cladribine MRI
Study Group. Neurology 54:1145–1155. CrossRef Medline
RodriguezM, Scheithauer B (1994) Ultrastructure of multiple sclerosis. Ul-
trastruct Pathol 18:3–13. CrossRef Medline
Scalfari A, Neuhaus A, Degenhardt A, Rice GP,Muraro PA,DaumerM, Ebers
GC (2010) The natural history of multiple sclerosis: a geographically
based study 10: relapses and long-term disability. Brain 133:1914–1929.
CrossRef Medline
Slowik A, Schmidt T, Beyer C, Amor S, Clarner T, Kipp M (2015) The sph-
ingosine 1-phosphate receptor agonist FTY720 is neuroprotective after
cuprizone-induced CNS demyelination. Br J Pharmacol 172:80–92.
CrossRef Medline
Stys PK, Zamponi GW, van Minnen J, Geurts JJ (2012) Will the real multi-
ple sclerosis please stand up? Nat Rev Neurosci 13:507–514. CrossRef
Medline
Scheld, Ru¨ther et al. • Neurodegeneration Triggers Immune Cell Recruitment J. Neurosci., January 27, 2016 • 36(4):1410–1415 • 1415
